AtonRa Partners - Q2 2021 holdings

$273 Million is the total value of AtonRa Partners's 112 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .

 Value Shares↓ Weighting
CBAY ExitCYMABAY THER REG$0-111,525
-100.0%
-0.23%
BMRN ExitBIOMARIN PHARMACEUTICAL INC$0-7,429
-100.0%
-0.25%
IONS ExitIONIS PHARMACEUTICALS INC$0-20,146
-100.0%
-0.40%
REGN ExitREGENERON PHARMACEUTICALS INC$0-2,067
-100.0%
-0.44%
PFPT ExitPROOFPOINT INC$0-9,347
-100.0%
-0.52%
RGNX ExitREGENXBIO INC$0-60,033
-100.0%
-0.91%
ILMN ExitILLUMINA INC$0-5,670
-100.0%
-0.97%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-13,319
-100.0%
-1.28%
TCEHY ExitTENCENT MUSIC ENTMT GROUPspon ads$0-45,118
-100.0%
-1.61%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2021-09-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SQUARE INC12Q3 20232.9%
SHOCKWAVE MED INC12Q3 20232.9%
INSULET CORP12Q3 20232.8%
SOLAREDGE TECHNOLOGIES INC12Q3 20232.5%
GUARDANT HEALTH INC12Q3 20234.3%
NVIDIA CORPORATION12Q3 20232.5%
INTUIT INC12Q3 20231.8%
ENPHASE ENERGY INC12Q3 20232.9%
LATTICE SEMICONDUCTOR CORP12Q3 20232.0%
DEXCOM INC12Q3 20232.1%

View AtonRa Partners's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-05
13F-HR2023-10-25
13F-HR2023-07-18
13F-HR2023-05-05
13F-HR2023-02-02
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View AtonRa Partners's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export AtonRa Partners's holdings